Takeda partners with Kyoto University to develop drugs for obesity and schizophrenia

Takeda Pharmaceutical Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Research Partner

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Kyoto University

Japan / Academic

Research Partner

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced